NCT07522697 2026-04-13MITO END-4National Cancer Institute, NaplesPhase 2 Not yet recruiting48 enrolled
NCT04645160 2026-04-07Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Recruiting31 enrolled
NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT05868629 2026-04-01Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid TumorsNovartisRecruiting40 enrolled
NCT06667141 2026-03-23Phase 1 Study of ACR-2316 in Specific Advanced Solid TumorsAcrivon TherapeuticsPhase 1 Recruiting100 enrolled